Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Aceso Life Science Group Limited ( (HK:0474) ) has issued an update.
Aceso Life Science Group Limited announced a forced sale of 1,385,116,000 shares in Hao Tian International Construction Investment Group Limited due to a loan default. This sale reduced Aceso’s shareholding in HTICI from 28.16% to 10.27%, impacting its investment portfolio and potentially affecting stakeholder interests.
More about Aceso Life Science Group Limited
Aceso Life Science Group Limited operates in the life sciences industry, focusing on biotechnology and related services. The company is incorporated in the Cayman Islands and is listed on the Hong Kong Stock Exchange.
Average Trading Volume: 1,299,655
Technical Sentiment Signal: Sell
Current Market Cap: HK$155M
Find detailed analytics on 0474 stock on TipRanks’ Stock Analysis page.